-
1
-
-
0042894451
-
Tyrian purple: 6,6′-dibromoindigo and related compounds
-
Cooksey CJ. Tyrian purple: 6,6′-dibromoindigo and related compounds. Molecules 2001; 6: 736-69.
-
(2001)
Molecules
, vol.6
, pp. 736-769
-
-
Cooksey, C.J.1
-
4
-
-
0033128165
-
Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases
-
Hoessel R, Leclerc S, Endicott J, et al. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat Cell Biol 1999; 1: 60-7.
-
(1999)
Nat Cell Biol
, vol.1
, pp. 60-67
-
-
Hoessel, R.1
Leclerc, S.2
Endicott, J.3
-
5
-
-
0035963318
-
Anti-mitotic properties of indirubin-3′-monoxime, a CDK/GSK-3 inhibitor: Induction of endoreplication following prophase arrest
-
Damiens E, Baratte B, Marie D, et al. Anti-mitotic properties of indirubin-3′-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest. Oncogene 2001; 20: 3786-97.
-
(2001)
Oncogene
, vol.20
, pp. 3786-3797
-
-
Damiens, E.1
Baratte, B.2
Marie, D.3
-
6
-
-
0034988970
-
Inhibitor binding to active and inactive CDK2. The crystal structure of a CDK2-cyclin A/indirubin-5-sulphonate
-
Davies TG, Tunnah P, Meijer L, et al. Inhibitor binding to active and inactive CDK2. The crystal structure of a CDK2-cyclin A/indirubin-5-sulphonate. Structure 2001; 9: 389-97.
-
(2001)
Structure
, vol.9
, pp. 389-397
-
-
Davies, T.G.1
Tunnah, P.2
Meijer, L.3
-
7
-
-
0242710962
-
Structures of P. falciparum PfPK5 test the CDK regulation paradigm and suggest mechanisms of small molecule inhibition
-
Holton S, Merckx A, Burgess D, et al. Structures of P. falciparum PfPK5 test the CDK regulation paradigm and suggest mechanisms of small molecule inhibition. Structure 2003; 11: 1329-37.
-
(2003)
Structure
, vol.11
, pp. 1329-1337
-
-
Holton, S.1
Merckx, A.2
Burgess, D.3
-
8
-
-
0035808457
-
Indirubins inhibit glycogen synthase kinase-3β and CDK5/p25, two kinases involved in abnormal tau phosphorylation in Alzheimer's disease - A property common to most CDK inhibitors?
-
Leclerc S, Garnier M, Hoessel R, et al. Indirubins inhibit glycogen synthase kinase-3β and CDK5/p25, two kinases involved in abnormal tau phosphorylation in Alzheimer's disease - a property common to most CDK inhibitors? J Biol Chem 2001; 276: 251-60.
-
(2001)
J Biol Chem
, vol.276
, pp. 251-260
-
-
Leclerc, S.1
Garnier, M.2
Hoessel, R.3
-
9
-
-
0346875916
-
GSK-3 selective inhibitors derived from Tyrian purple indirubins
-
Meijer L, Skaltsounis AL, Magiatis P, et al. GSK-3 selective inhibitors derived from Tyrian purple indirubins. Chem Biol 2003; 10: 1255-66.
-
(2003)
Chem Biol
, vol.10
, pp. 1255-1266
-
-
Meijer, L.1
Skaltsounis, A.L.2
Magiatis, P.3
-
10
-
-
2442589341
-
Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases
-
Polychronopoulos P, Magiatis P, Skaltsounis L, et al. Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases. J Med Chem 2004; 47: 935-46.
-
(2004)
J Med Chem
, vol.47
, pp. 935-946
-
-
Polychronopoulos, P.1
Magiatis, P.2
Skaltsounis, L.3
-
11
-
-
0346338117
-
CDK versus GSK-3 inhibition: A purple haze no longer?
-
Fischer PM. CDK versus GSK-3 inhibition: a purple haze no longer? Chem Biol 2003; 10: 1144-6.
-
(2003)
Chem Biol
, vol.10
, pp. 1144-1146
-
-
Fischer, P.M.1
-
12
-
-
1242267927
-
Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3 specific inhibitor
-
Sato N, Meijer L, Skaltsounis L, et al. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3 specific inhibitor. Nat Med 2004; 10: 55-63.
-
(2004)
Nat Med
, vol.10
, pp. 55-63
-
-
Sato, N.1
Meijer, L.2
Skaltsounis, L.3
-
13
-
-
2442575199
-
Balard, so vie, son œuvre à Montpellier de 1802 à 1840
-
Dolique R. Balard, so vie, son œuvre à Montpellier de 1802 à 1840. Rev Hist Pharm 1977; 232: 13-27.
-
(1977)
Rev Hist Pharm
, vol.232
, pp. 13-27
-
-
Dolique, R.1
|